Serum Institute Of India
-
PM Modi's 3-city tour to take stock of COVID-19 vaccine development on Saturday
India | Nov 27, 2020, 11:05 PM ISTPrime Minister Narendra Modi will embark on a three-city visit tomorrow to personally review the coronavirus vaccines development and manufacturing process.
-
PM Modi likely to visit Pune's Serum Institute of India tomorrow
News | Nov 27, 2020, 08:40 AM ISTPrime Minister Narendra Modi on Saturday will visit the Serum Institute of India in Pune, which has partnered with global pharma giant AstraZeneca and the Oxford University for COVID-19 vaccine, a senior official told PTI on Thursday.
-
PM Modi to visit Pune's Serum Institute of India on November 28, likely to review vaccine status
India | Nov 26, 2020, 06:02 PM ISTPrime Minister Narendra Modi on Saturday will visit the Serum Institute of India in Pune, which has partnered with global pharma giant AstraZeneca and the Oxford University for COVID-19 vaccine, a senior official told PTI on Thursday.
-
In touch with Serum CEO, task force formed to manage COVID-19 vaccine distribution: Uddhav tells PM
India | Nov 24, 2020, 01:43 PM ISTMaharashtra Chief Minister Uddhav Thackeray on Tuesday informed Prime Minister Narendra Modi that the state has formed a task force to ensure timely distribution of coronavirus vaccine. At a virtual meeting with PM Modi, Thackeray said the state government is in touch with Adar Poonawalla, CEO of Serum Institute of India (SII), which is the partner in the Oxford-AstraZeneca vaccine for coronavirus.
-
Serum Institute, Bharat Biotech to begin intranasal coronavirus vaccine trials: Harsh Vardhan
India | Oct 19, 2020, 12:48 PM ISTPune based Serum Institute of India and Bharat Biotech are likely to conduct late-stage clinical trials of intranasal coronavirus vaccine once they receive regulatory approval, Health Minister Harsh Vardhan said on Sunday. The clinical trials of nasal coronavirus vaccine in India are expected to start in a few months.
-
Covishield: COVID-19 vaccine may be ready by December, in market by March, says Serum Institute
India | Oct 18, 2020, 12:17 PM ISTAt present, Pune-based drug SII is conducting phase 2 and 3 trials of the coronavirus vaccine. Serum Institute of India can produce 700-800 million vaccine dosages every year once things are streamlined, Dr Jadav added.
-
Serum Institute of India to produce additional 100 million COVID-19 vaccine doses for India
India | Sep 29, 2020, 02:21 PM ISTThe Serum Institute of India (SII) on Tuesday said it would produce upto an additional 100 million COVID-19 vaccine doses for India in 2021. Other than for India, the COVID-19 vaccines will also be produced for low and middle-income countries, the Serum Institute of India said.